Drugs Affecting Lipid Metabolism:
A great deal of experimental, clinical and epidemiological data have been gathered to confirm the strict and causal correlation between plasma lipoproteins and coronary heart disease. However, as usually happens in research, many more interesting issues are being studied, opening new fields of resea...
Gespeichert in:
| Weitere Verfasser: | , , , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Dordrecht
Springer Netherlands
1993
|
| Schriftenreihe: | Medical Science Symposia Series
2 |
| Schlagworte: | |
| Online-Zugang: | UBR01 Volltext |
| Zusammenfassung: | A great deal of experimental, clinical and epidemiological data have been gathered to confirm the strict and causal correlation between plasma lipoproteins and coronary heart disease. However, as usually happens in research, many more interesting issues are being studied, opening new fields of research for the future. These new advances, together with the combined efforts of cell biologists and lipoprotein chemists, have set the pace for an exciting period of research and clinical applications of diets and drugs affecting plasma and cell lipids. This volume, which includes the work of many of the leading world labortories, represents an authoritative and up-to-date appraisal of the status of the art and a stimulus to future research at the laboratory and clinical level in a fascinating area of clinical and preventive medicine |
| Beschreibung: | 1 Online-Ressource (XX, 520 p) |
| ISBN: | 9789401117036 |
| DOI: | 10.1007/978-94-011-1703-6 |
Internformat
MARC
| LEADER | 00000nmm a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV046145398 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 190905s1993 |||| o||u| ||||||eng d | ||
| 020 | |a 9789401117036 |9 978-94-011-1703-6 | ||
| 024 | 7 | |a 10.1007/978-94-011-1703-6 |2 doi | |
| 035 | |a (ZDB-2-SME)978-94-011-1703-6 | ||
| 035 | |a (OCoLC)1119030088 | ||
| 035 | |a (DE-599)BVBBV046145398 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 082 | 0 | |a 616.12 |2 23 | |
| 084 | |a XI 4905 |0 (DE-625)153009:12911 |2 rvk | ||
| 245 | 1 | 0 | |a Drugs Affecting Lipid Metabolism |c edited by A. L. Catapano, A. M. Gotto, Louis C. Smith, Rodolfo Paoletti |
| 264 | 1 | |a Dordrecht |b Springer Netherlands |c 1993 | |
| 300 | |a 1 Online-Ressource (XX, 520 p) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Medical Science Symposia Series |v 2 | |
| 520 | |a A great deal of experimental, clinical and epidemiological data have been gathered to confirm the strict and causal correlation between plasma lipoproteins and coronary heart disease. However, as usually happens in research, many more interesting issues are being studied, opening new fields of research for the future. These new advances, together with the combined efforts of cell biologists and lipoprotein chemists, have set the pace for an exciting period of research and clinical applications of diets and drugs affecting plasma and cell lipids. This volume, which includes the work of many of the leading world labortories, represents an authoritative and up-to-date appraisal of the status of the art and a stimulus to future research at the laboratory and clinical level in a fascinating area of clinical and preventive medicine | ||
| 650 | 4 | |a Cardiology | |
| 650 | 4 | |a Internal Medicine | |
| 650 | 4 | |a Cardiology | |
| 650 | 4 | |a Internal medicine | |
| 650 | 0 | 7 | |a Hyperlipidämie |0 (DE-588)4161072-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Chemotherapie |0 (DE-588)4127083-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Atherogenese |0 (DE-588)4195269-8 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmakologie |0 (DE-588)4045687-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Lipidstoffwechsel |0 (DE-588)4035875-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Lipidstoffwechselstörung |0 (DE-588)4035876-8 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Lipidsenker |0 (DE-588)4167796-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmakotherapie |0 (DE-588)4076066-2 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1992 |z Florenz |2 gnd-content | |
| 689 | 0 | 0 | |a Hyperlipidämie |0 (DE-588)4161072-6 |D s |
| 689 | 0 | 1 | |a Atherogenese |0 (DE-588)4195269-8 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Hyperlipidämie |0 (DE-588)4161072-6 |D s |
| 689 | 1 | 1 | |a Chemotherapie |0 (DE-588)4127083-6 |D s |
| 689 | 1 | |5 DE-604 | |
| 689 | 2 | 0 | |a Hyperlipidämie |0 (DE-588)4161072-6 |D s |
| 689 | 2 | 1 | |a Pharmakotherapie |0 (DE-588)4076066-2 |D s |
| 689 | 2 | |5 DE-604 | |
| 689 | 3 | 0 | |a Lipidstoffwechsel |0 (DE-588)4035875-6 |D s |
| 689 | 3 | 1 | |a Pharmakologie |0 (DE-588)4045687-0 |D s |
| 689 | 3 | |5 DE-604 | |
| 689 | 4 | 0 | |a Lipidsenker |0 (DE-588)4167796-1 |D s |
| 689 | 4 | |5 DE-604 | |
| 689 | 5 | 0 | |a Lipidstoffwechselstörung |0 (DE-588)4035876-8 |D s |
| 689 | 5 | |5 DE-604 | |
| 700 | 1 | |a Catapano, A. L. |4 edt | |
| 700 | 1 | |a Gotto, A. M. |4 edt | |
| 700 | 1 | |a Smith, Louis C. |4 edt | |
| 700 | 1 | |a Paoletti, Rodolfo |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9780792322320 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9789401117043 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9789401047463 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-94-011-1703-6 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-2-SME | ||
| 940 | 1 | |q ZDB-2-SME_1990/2004 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-031525583 | ||
| 966 | e | |u https://doi.org/10.1007/978-94-011-1703-6 |l UBR01 |p ZDB-2-SME |q ZDB-2-SME_1990/2004 |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804180482013790208 |
|---|---|
| any_adam_object | |
| author2 | Catapano, A. L. Gotto, A. M. Smith, Louis C. Paoletti, Rodolfo |
| author2_role | edt edt edt edt |
| author2_variant | a l c al alc a m g am amg l c s lc lcs r p rp |
| author_facet | Catapano, A. L. Gotto, A. M. Smith, Louis C. Paoletti, Rodolfo |
| building | Verbundindex |
| bvnumber | BV046145398 |
| classification_rvk | XI 4905 |
| collection | ZDB-2-SME |
| ctrlnum | (ZDB-2-SME)978-94-011-1703-6 (OCoLC)1119030088 (DE-599)BVBBV046145398 |
| dewey-full | 616.12 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.12 |
| dewey-search | 616.12 |
| dewey-sort | 3616.12 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| doi_str_mv | 10.1007/978-94-011-1703-6 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03858nmm a2200793zcb4500</leader><controlfield tag="001">BV046145398</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190905s1993 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9789401117036</subfield><subfield code="9">978-94-011-1703-6</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-94-011-1703-6</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-94-011-1703-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1119030088</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046145398</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.12</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 4905</subfield><subfield code="0">(DE-625)153009:12911</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Drugs Affecting Lipid Metabolism</subfield><subfield code="c">edited by A. L. Catapano, A. M. Gotto, Louis C. Smith, Rodolfo Paoletti</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Dordrecht</subfield><subfield code="b">Springer Netherlands</subfield><subfield code="c">1993</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XX, 520 p)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Medical Science Symposia Series</subfield><subfield code="v">2</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">A great deal of experimental, clinical and epidemiological data have been gathered to confirm the strict and causal correlation between plasma lipoproteins and coronary heart disease. However, as usually happens in research, many more interesting issues are being studied, opening new fields of research for the future. These new advances, together with the combined efforts of cell biologists and lipoprotein chemists, have set the pace for an exciting period of research and clinical applications of diets and drugs affecting plasma and cell lipids. This volume, which includes the work of many of the leading world labortories, represents an authoritative and up-to-date appraisal of the status of the art and a stimulus to future research at the laboratory and clinical level in a fascinating area of clinical and preventive medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Internal Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Internal medicine</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Hyperlipidämie</subfield><subfield code="0">(DE-588)4161072-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Chemotherapie</subfield><subfield code="0">(DE-588)4127083-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Atherogenese</subfield><subfield code="0">(DE-588)4195269-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Lipidstoffwechsel</subfield><subfield code="0">(DE-588)4035875-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Lipidstoffwechselstörung</subfield><subfield code="0">(DE-588)4035876-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Lipidsenker</subfield><subfield code="0">(DE-588)4167796-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1992</subfield><subfield code="z">Florenz</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Hyperlipidämie</subfield><subfield code="0">(DE-588)4161072-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Atherogenese</subfield><subfield code="0">(DE-588)4195269-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Hyperlipidämie</subfield><subfield code="0">(DE-588)4161072-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Chemotherapie</subfield><subfield code="0">(DE-588)4127083-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Hyperlipidämie</subfield><subfield code="0">(DE-588)4161072-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="3" ind2="0"><subfield code="a">Lipidstoffwechsel</subfield><subfield code="0">(DE-588)4035875-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2="1"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="4" ind2="0"><subfield code="a">Lipidsenker</subfield><subfield code="0">(DE-588)4167796-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="4" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="5" ind2="0"><subfield code="a">Lipidstoffwechselstörung</subfield><subfield code="0">(DE-588)4035876-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="5" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Catapano, A. L.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gotto, A. M.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Smith, Louis C.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Paoletti, Rodolfo</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9780792322320</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9789401117043</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9789401047463</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-94-011-1703-6</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_1990/2004</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031525583</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-94-011-1703-6</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="q">ZDB-2-SME_1990/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 1992 Florenz gnd-content |
| genre_facet | Konferenzschrift 1992 Florenz |
| id | DE-604.BV046145398 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T08:36:27Z |
| institution | BVB |
| isbn | 9789401117036 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031525583 |
| oclc_num | 1119030088 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 1 Online-Ressource (XX, 520 p) |
| psigel | ZDB-2-SME ZDB-2-SME_1990/2004 ZDB-2-SME ZDB-2-SME_1990/2004 |
| publishDate | 1993 |
| publishDateSearch | 1993 |
| publishDateSort | 1993 |
| publisher | Springer Netherlands |
| record_format | marc |
| series2 | Medical Science Symposia Series |
| spelling | Drugs Affecting Lipid Metabolism edited by A. L. Catapano, A. M. Gotto, Louis C. Smith, Rodolfo Paoletti Dordrecht Springer Netherlands 1993 1 Online-Ressource (XX, 520 p) txt rdacontent c rdamedia cr rdacarrier Medical Science Symposia Series 2 A great deal of experimental, clinical and epidemiological data have been gathered to confirm the strict and causal correlation between plasma lipoproteins and coronary heart disease. However, as usually happens in research, many more interesting issues are being studied, opening new fields of research for the future. These new advances, together with the combined efforts of cell biologists and lipoprotein chemists, have set the pace for an exciting period of research and clinical applications of diets and drugs affecting plasma and cell lipids. This volume, which includes the work of many of the leading world labortories, represents an authoritative and up-to-date appraisal of the status of the art and a stimulus to future research at the laboratory and clinical level in a fascinating area of clinical and preventive medicine Cardiology Internal Medicine Internal medicine Hyperlipidämie (DE-588)4161072-6 gnd rswk-swf Chemotherapie (DE-588)4127083-6 gnd rswk-swf Atherogenese (DE-588)4195269-8 gnd rswk-swf Pharmakologie (DE-588)4045687-0 gnd rswk-swf Lipidstoffwechsel (DE-588)4035875-6 gnd rswk-swf Lipidstoffwechselstörung (DE-588)4035876-8 gnd rswk-swf Lipidsenker (DE-588)4167796-1 gnd rswk-swf Pharmakotherapie (DE-588)4076066-2 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1992 Florenz gnd-content Hyperlipidämie (DE-588)4161072-6 s Atherogenese (DE-588)4195269-8 s DE-604 Chemotherapie (DE-588)4127083-6 s Pharmakotherapie (DE-588)4076066-2 s Lipidstoffwechsel (DE-588)4035875-6 s Pharmakologie (DE-588)4045687-0 s Lipidsenker (DE-588)4167796-1 s Lipidstoffwechselstörung (DE-588)4035876-8 s Catapano, A. L. edt Gotto, A. M. edt Smith, Louis C. edt Paoletti, Rodolfo edt Erscheint auch als Druck-Ausgabe 9780792322320 Erscheint auch als Druck-Ausgabe 9789401117043 Erscheint auch als Druck-Ausgabe 9789401047463 https://doi.org/10.1007/978-94-011-1703-6 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | Drugs Affecting Lipid Metabolism Cardiology Internal Medicine Internal medicine Hyperlipidämie (DE-588)4161072-6 gnd Chemotherapie (DE-588)4127083-6 gnd Atherogenese (DE-588)4195269-8 gnd Pharmakologie (DE-588)4045687-0 gnd Lipidstoffwechsel (DE-588)4035875-6 gnd Lipidstoffwechselstörung (DE-588)4035876-8 gnd Lipidsenker (DE-588)4167796-1 gnd Pharmakotherapie (DE-588)4076066-2 gnd |
| subject_GND | (DE-588)4161072-6 (DE-588)4127083-6 (DE-588)4195269-8 (DE-588)4045687-0 (DE-588)4035875-6 (DE-588)4035876-8 (DE-588)4167796-1 (DE-588)4076066-2 (DE-588)1071861417 |
| title | Drugs Affecting Lipid Metabolism |
| title_auth | Drugs Affecting Lipid Metabolism |
| title_exact_search | Drugs Affecting Lipid Metabolism |
| title_full | Drugs Affecting Lipid Metabolism edited by A. L. Catapano, A. M. Gotto, Louis C. Smith, Rodolfo Paoletti |
| title_fullStr | Drugs Affecting Lipid Metabolism edited by A. L. Catapano, A. M. Gotto, Louis C. Smith, Rodolfo Paoletti |
| title_full_unstemmed | Drugs Affecting Lipid Metabolism edited by A. L. Catapano, A. M. Gotto, Louis C. Smith, Rodolfo Paoletti |
| title_short | Drugs Affecting Lipid Metabolism |
| title_sort | drugs affecting lipid metabolism |
| topic | Cardiology Internal Medicine Internal medicine Hyperlipidämie (DE-588)4161072-6 gnd Chemotherapie (DE-588)4127083-6 gnd Atherogenese (DE-588)4195269-8 gnd Pharmakologie (DE-588)4045687-0 gnd Lipidstoffwechsel (DE-588)4035875-6 gnd Lipidstoffwechselstörung (DE-588)4035876-8 gnd Lipidsenker (DE-588)4167796-1 gnd Pharmakotherapie (DE-588)4076066-2 gnd |
| topic_facet | Cardiology Internal Medicine Internal medicine Hyperlipidämie Chemotherapie Atherogenese Pharmakologie Lipidstoffwechsel Lipidstoffwechselstörung Lipidsenker Pharmakotherapie Konferenzschrift 1992 Florenz |
| url | https://doi.org/10.1007/978-94-011-1703-6 |
| work_keys_str_mv | AT catapanoal drugsaffectinglipidmetabolism AT gottoam drugsaffectinglipidmetabolism AT smithlouisc drugsaffectinglipidmetabolism AT paolettirodolfo drugsaffectinglipidmetabolism |